Pregnancy

[키워드] 1:1 aetiology agreement allocation Anosmia anticipated Arm ARMS Asymptomatic automatically Barcelona blinded block randomization Cardiac pathology change characterized chills clinical Clinical course clinical trial close contact collected Compound Concomitant conducted confirmed COVID-19 case Contact cough Course COVID-19 COVID-19 disease COVID-19 disease severity CRF criteria delivery determine diarrhoea dissemination double-blind Dyspnoea ECDC Effect Efficacy Efficacy and safety element EudraCT evaluate evaluate the effect Fever FIVE gestation global health HCQ headache history hospital Hospitalization Hydroxychloroquine hypersensitivity inclusion criteria intervention study investigator Liver disease Mild mild symptoms Mortality multicentre nasopharyngeal number objective oropharyngeal swab outcome packaged Pain participant Patient PCR PCR-confirmed Placebo placebo controlled trial placebo-controlled Pregnancy pregnant pregnant women prenatal Prevent Primary outcome progression protocol randomised randomised controlled trial Randomized receive recruited recruitment reducing Registered risk Sample size SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR SARS-CoV-2 viral shedding status stratified study group study participant Study protocol subsequent Symptom symptomatic syndrome Tablet Tolerability Transmission Treatment treatment group Trial Two-arm uterine website women
[DOI] 10.1186/s13063-020-04557-y PMC 바로가기 [Article Type] Letter